Changes in Body Mass Index with Longer-term Integrase Inhibitor Use: A Longitudinal Analysis of Data from the Randomized Trial to Prevent Vascular Events in Human Immunodeficiency Virus (REPRIEVE)

Abstract Over 2-years of follow-up, integrase strand transfer inhibitor (INSTI)-use was associated with weight gain among those on an INSTI 2 years.

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical infectious diseases 2023-06, Vol.76 (11), p.2010-2013
Hauptverfasser:	Kileel, Emma M, Malvestutto, Carlos D, Lo, Janet, Fitch, Kathleen V, Fichtenbaum, Carl J, Aberg, Judith A, Zanni, Markella V, Martinez, Esteban, Okeke, Nwora Lance, Kumar, Princy, Joao, Esau, Bares, Sara H, Berrner, Daniel, Smieja, Marek, Roa, Jhoanna C, McCallum, Sara, Douglas, Pamela S, Ribaudo, Heather J, Grinspoon, Steven K
Format:	Artikel
Sprache:	eng
Schlagworte:	Body Mass Index Drug Resistance, Viral HIV Infections - drug therapy HIV Infections - prevention & control HIV Integrase HIV Integrase Inhibitors - pharmacology HIV Integrase Inhibitors - therapeutic use HIV-1 Humans
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Abstract Over 2-years of follow-up, integrase strand transfer inhibitor (INSTI)-use was associated with weight gain among those on an INSTI 2 years.
ISSN:	1058-4838 1537-6591 1537-6591
DOI:	10.1093/cid/ciad107